IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 142 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $301,000 | -3.5% | 19,662 | 0.0% | 0.09% | +3.6% |
Q3 2016 | $312,000 | +21.4% | 19,662 | 0.0% | 0.08% | +31.2% |
Q2 2016 | $257,000 | +19.5% | 19,662 | 0.0% | 0.06% | +18.5% |
Q1 2016 | $215,000 | -5.7% | 19,662 | 0.0% | 0.05% | -1.8% |
Q4 2015 | $228,000 | +11.2% | 19,662 | 0.0% | 0.06% | -5.2% |
Q3 2015 | $205,000 | -13.5% | 19,662 | 0.0% | 0.06% | -12.1% |
Q2 2015 | $237,000 | -24.8% | 19,662 | 0.0% | 0.07% | -20.5% |
Q1 2015 | $315,000 | +4.7% | 19,662 | 0.0% | 0.08% | +6.4% |
Q4 2014 | $301,000 | +18.0% | 19,662 | 0.0% | 0.08% | +2.6% |
Q3 2014 | $255,000 | -15.3% | 19,662 | 0.0% | 0.08% | -8.4% |
Q2 2014 | $301,000 | +24.4% | 19,662 | 0.0% | 0.08% | +18.6% |
Q1 2014 | $242,000 | +6.1% | 19,662 | 0.0% | 0.07% | +2.9% |
Q4 2013 | $228,000 | -2.1% | 19,662 | 0.0% | 0.07% | -6.8% |
Q3 2013 | $233,000 | +19.5% | 19,662 | 0.0% | 0.07% | +23.7% |
Q2 2013 | $195,000 | – | 19,662 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,597,065 | $72,510,000 | 15.06% |
SOUND ENERGY PARTNERS, INC. | 400,566 | $5,189,000 | 4.02% |
SECTOR GAMMA AS | 1,138,291 | $14,747,000 | 3.45% |
Orbimed Advisors | 12,012,100 | $155,617,000 | 1.62% |
SHAPIRO ROBERT N | 485,974 | $6,296,000 | 1.20% |
Broderick Brian C | 166,345 | $2,156,000 | 0.96% |
Hall Kathryn A. | 193,588 | $2,508,000 | 0.65% |
Tekla Capital Management LLC | 768,050 | $9,950,000 | 0.47% |
PARADIGM ASSET MANAGEMENT CO LLC | 180,800 | $2,342,264,000 | 0.33% |
BOURGEON CAPITAL MANAGEMENT LLC | 42,800 | $554,000 | 0.32% |